Skip to main content
Have a personal or library account? Click to login
Transcatheter Valve Replacement: Risk Levels and Contemporary Outcomes Cover

Transcatheter Valve Replacement: Risk Levels and Contemporary Outcomes

Open Access
|Jul 2017

Abstract

Transcatheter aortic valve replacement (TAVR) has exploded into medical care for aortic stenosis, thus changing the treatment options for patients. TAVR is currently approved for extreme-risk, high-risk, and intermediate-risk patients with symptomatic severe aortic stenosis, and randomized trials for low-risk patients are underway. This article traces the trajectory of TAVR as a viable option for higher-risk patients and examines current outcomes.

Language: English
Page range: 126 - 131
Published on: Jul 1, 2017
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services

© 2017 Manuel Reyes, Michael J. Reardon, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.